ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schlüter Agatha, Vélez-Santamaría Valentina, Verdura Edgard, Rodríguez-Palmero Agustí, Ruiz Montserrat, Fourcade Stéphane, Planas-Serra Laura, Launay Nathalie, Guilera Cristina, Martínez Juan José, Homedes-Pedret Christian, Albertí-Aguiló M Antonia, Zulaika Miren, Martí Itxaso, Troncoso Mónica, Tomás-Vila Miguel, Bullich Gemma, García-Pérez M Asunción, Sobrido-Gómez María-Jesús, López-Laso Eduardo, Fons Carme, Del Toro Mireia, Macaya Alfons, HSP/ataxia workgroup, Beltran Sergi, Gutiérrez-Solana Luis G, Pérez-Jurado Luis A, Aguilera-Albesa Sergio, de Munain Adolfo López, Casasnovas Carlos, Pujol Aurora
Аннотация
METHODS: We developed ClinPrior, a novel method for the analysis of WES/WGS data that ranks candidate causal variants based on the patient's standardized phenotypic features (in Human Phenotype Ontology (HPO) terms). The algorithm propagates the data through an interactome network-based prioritization approach. This algorithm was thoroughly benchmarked using a synthetic patient cohort and was subsequently tested on a heterogeneous prospective, real-world series of 135 families affected by hereditary spastic paraplegia (HSP) and/or cerebellar ataxia (CA).
RESULTS: ClinPrior successfully identified causative variants achieving a final positive diagnostic yield of 70% in our real-world cohort. This includes 10 novel candidate genes not previously associated with disease, 7 of which were functionally validated within this project. We used the knowledge generated by ClinPrior to create a specific interactome for HSP/CA disorders thus enabling future diagnoses as well as the discovery of novel disease genes.
CONCLUSIONS: ClinPrior is an algorithm that uses standardized phenotype information and interactome data to improve clinical genomic diagnosis. It helps in identifying atypical cases and efficiently predicts novel disease-causing genes. This leads to increasing diagnostic yield, shortening of the diagnostic Odysseys and advancing our understanding of human illnesses.